Sale!

EIF2AK4 Gene Pulmonary Venoocclusive Disease Type 2 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The EIF2AK4 gene pulmonary venoocclusive disease type 2 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the EIF2AK4 gene, which are known to cause pulmonary venoocclusive disease (PVOD) type 2. This condition is a rare form of pulmonary hypertension characterized by the obstruction of small veins in the lungs, leading to significant breathing difficulties and heart failure if left untreated. The genetic test is crucial for early diagnosis and management of the condition, providing vital information for personalized treatment plans.

Performed at DNA Labs UAE, the test involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific genetic alterations in the EIF2AK4 gene. The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the expertise required to accurately interpret the results. By identifying individuals with these genetic mutations, healthcare providers can offer targeted interventions, potentially improving outcomes and quality of life for those affected by PVOD type 2.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

EIF2AK4 Gene Pulmonary Venoocclusive Disease Type 2 Genetic Test

At DNA Labs UAE, we offer the EIF2AK4 Gene Pulmonary Venoocclusive Disease Type 2 Genetic Test. This test is designed to detect the presence of the EIF2AK4 gene associated with pulmonary venoocclusive disease type 2 (PVOD2).

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cardiovascular Pneumology Disorders
  • Doctor: Cardiologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the EIF2AK4 Gene Pulmonary Venoocclusive Disease Type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by PVOD2.

Test Details

The EIF2AK4 gene is associated with pulmonary venoocclusive disease type 2 (PVOD2), a rare genetic disorder that affects the blood vessels in the lungs. This leads to high blood pressure in the pulmonary arteries. The NGS genetic testing method, which utilizes advanced sequencing technologies, is used to analyze multiple genes simultaneously.

In the context of PVOD2, NGS genetic testing can identify mutations or variations in the EIF2AK4 gene that may be responsible for the disease. This information is crucial for diagnosing PVOD2, determining the risk of developing the disease, and providing guidance for genetic counseling and family planning.

NGS testing also aids in the development of personalized treatment strategies for individuals with PVOD2. It is important to note that this genetic testing should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

Test Name EIF2AK4 Gene Pulmonary venoocclusive disease type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EIF2AK4 Gene Pulmonary venoocclusive disease type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EIF2AK4 Gene Pulmonary venoocclusive disease type 2 NGS Genetic DNA Test gene EIF2AK4
Test Details

The EIF2AK4 gene is associated with pulmonary venoocclusive disease type 2 (PVOD2). PVOD2 is a rare genetic disorder that affects the blood vessels in the lungs, leading to high blood pressure in the pulmonary arteries.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of PVOD2, NGS genetic testing can be used to identify mutations or variations in the EIF2AK4 gene that may be responsible for the disease.

By identifying these genetic variations, NGS testing can help in diagnosing PVOD2, determining the risk of developing the disease, and providing information for genetic counseling and family planning. It can also aid in the development of personalized treatment strategies for individuals with PVOD2.

It is important to note that NGS genetic testing should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.